GUTS: Revita targets the urgent post-GLP-1 weight maintenance gap with scalable, cost-effective therapy
Post-GLP-1 weight regain is a major unmet need, with millions of patients lacking durable maintenance options. Revita, a one-time endoscopic procedure, shows strong efficacy and safety, with a large addressable market and a focused commercialization plan targeting high-volume centers. Break-even is…
Post-GLP-1 weight regain is a major unmet need, with millions of patients lacking durable maintenance options.
Revita, a one-time endoscopic procedure, shows strong efficacy and safety, with a large addressable market and a focused commercialization plan targeting high-volume centers.
Break-even is…